Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2018
At a glance
- Drugs Cixutumumab (Primary)
- Indications Mesothelioma
- Focus Pharmacogenomic; Therapeutic Use
- 13 Mar 2018 Status changed from active, no longer recruiting to completed.
- 27 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 31 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Jan 2017.